Continuing evolution of migraine-specific therapies — targeting migraine with precision and persistence

Dimos D. Mitsikostas,Alan Rapoport

DOI: https://doi.org/10.1038/s41582-024-01026-x

IF: 38.1

2024-10-08

Nature Reviews Neurology

Abstract:Treatment options for migraine have expanded rapidly over the past few years. The latest success in a phase II trial of a new class of drugs for migraine holds the promise of another alternative, with important implications for our understanding of migraine and its clinical management.

clinical neurology